|
Research & Development
|
36.19M | 70.10M | 108.81M |
|
Selling, General & Administrative
|
16.37M | 32.67M | 49.41M |
|
Operating Expenses
|
52.56M | 102.78M | 158.23M |
|
Operating Income
|
-52.56M | -102.78M | -158.23M |
|
EBIT
|
-52.56M | -102.78M | -158.23M |
|
Interest & Investment Income
|
1.26M | 13.39M | 36.01M |
|
Non Operating Income
|
-0.06M | 0.01M | -0.02M |
|
EBT
|
-51.30M | -89.38M | -122.22M |
|
Tax Provisions
|
0.08M | 0.24M | 0.33M |
|
Profit After Tax
|
-51.32M | -89.62M | -122.53M |
|
Income from Continuing Operations
|
-51.38M | -89.62M | -122.54M |
|
Consolidated Net Income
|
-51.38M | -89.62M | -122.54M |
|
Income towards Parent Company
|
-51.38M | -89.62M | -122.54M |
|
Net Income towards Common Stockholders
|
-51.38M | -89.62M | -122.54M |
|
EPS (Basic)
|
-0.00M | -0.00M | -0.00M |
|
EPS (Weighted Average and Diluted)
|
-0.00M | -0.00M | -0.00M |
|
Shares Outstanding (Weighted Average)
|
77.54M | 139.16M | 171.78M |
|
EBITDA
|
-51.43M | -88.99M | -122.13M |